Coupling a body conduit to tissue

US9861726B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9861726-B2
Application numberUS-201514853652-A
CountryUS
Kind codeB2
Filing dateSep 14, 2015
Priority dateSep 15, 2014
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area, and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for coupling a body conduit to tissue, the method comprising: positioning an implant about an outer surface of a catheter, the implant configured to receive a bioactive agent having tissue growth properties; inserting the catheter through the body conduit and into a tissue opening, the tissue opening being spaced from the body conduit to define a resected area between the tissue opening and the body conduit; positioning the implant in the resected area; inflating a balloon of the catheter to anchor the catheter within the tissue opening such that the implant bridges the body conduit and the tissue opening across the resected area; and maintaining the catheter and the implant in vivo to enable the bioactive agent to secure the implant in the resected area to permanently bridge the body conduit and the tissue opening while maintaining the body conduit and the tissue opening spaced from one another via the implant. 2. The method of claim 1 , further including deflating the balloon to remove the catheter after the implant is permanently secured in vivo. 3. The method of claim 1 , wherein the bioactive agent includes at least one of epithelial cells, stem cells, epidermal growth factors, fibroblast growth factors, or chitosan. 4. The method of claim 1 , wherein positioning the implant about the outer surface of the catheter includes sliding the implant over the outer surface of the catheter, wherein the catheter includes a Foley catheter. 5. The method of claim 1 , further including impregnating the outer surface of the catheter with the bioactive agent and positioning the implant over an impregnated portion of the outer surface of the catheter. 6. The method of claim 1 , wherein the body conduit includes a resected urethra and the tissue opening is defined in a bladder, and wherein inserting the catheter includes advancing the catheter through an unresected portion of the resected urethra and into the bladder via the tissue opening such that the implant bridges the resected area defined between the unresected portion of the resected urethra and the bladder. 7. The method of claim 1 , further including inflating a second balloon to engage the implant with surrounding tissue. 8. The method of claim 1 , further including inflating a second balloon in a pulsatile manner. 9. The method of claim 7 , further including selectively exchanging fluid through a fluid passage defined between an inner surface of the implant and an outer surface of the second balloon.

Assignees

Inventors

Classifications

  • specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections · CPC title

  • Porous materials, {e.g. foams or sponges} · CPC title

  • End-to-side connections, e.g. T- or Y-connections · CPC title

  • enhancing wound closure · CPC title

  • mounted on or guided by flexible, e.g. catheter-like, means · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9861726B2 cover?
A method for coupling a body conduit to tissue is provided. The method includes engaging an implant about an outer surface of a catheter. The implant receives a bioactive agent having tissue growth properties. The method involves inserting the catheter through the body conduit and into a tissue opening across a resected area, positioning the implant in the resected area, inflating a balloon to …
Who is the assignee on this patent?
Covidien Lp
What technology area does this patent fall under?
Primary CPC classification A61L27/54. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).